Search
  1. Home
  2. East Africa
  3. Kenya
  • News

HIV vaccine trials to begin in December

    NAIROBI

    A preventive HIV vaccine trial is set to begin on 1 December in Nairobi, researchers from the Kenya Aids Vaccine Initiative (KAVI) told journalists last week. They said the trials will be done in three phases and will involve a small number of volunteers. The first phase will involve volunteers from the low risk group comprising those who have tested HIV negative and are not highly exposed to the virus. The experts stressed
    that the vaccine was preventive and not curative. The vaccine is also to go on trial in two months in London. It was developed after years of research between scientists at the University of Nairobi and the Oxford University.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join